
Giovan Giuseppe Di Costanzo, MD, Cardarelli Hospital, discusses a scoring system to predict the effectiveness of sorafenib (Nexavar) in hepatocellular carcinoma (HCC).

Your AI-Trained Oncology Knowledge Connection!


Published: May 24th 2017 | Updated: